Close

GW Pharma (GWPH) (GWP) Gains; Epidiolex Treatment Effect in Children

Go back to GW Pharma (GWPH) (GWP) Gains; Epidiolex Treatment Effect in Children

GW Pharma (GWPH) Price Target Raised to $155 at BofA/Merrill Lynch

April 23, 2015 11:28 AM EDT

BofA/Merrill Lynch maintained a Buy rating on GW Pharma (NASDAQ: GWPH) and raised its price target to $155.00 (from $115.00). Analyst Tazeen Ahmad noted the company's positive... More